The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury

Xenobiotica

Volumn 45, Issue 5, 2015, Pages 442-449

  McGill, Mitchell R ^a   Du, Kuo ^a   Xie, Yuchao ^a   Bajt, Mary Lynn ^a   Ding, Wen Xing ^a   Jaeschke, Hartmut ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death; Cell signaling; Hepatotoxicity; Kinases; Mitochondria

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; FUROSEMIDE; GLUTATHIONE; GLUTATHIONE DISULFIDE; MITOGEN ACTIVATED PROTEIN KINASE 9; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; ANTHRACENE DERIVATIVE; PYRAZOLANTHRONE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, HUMAN; RIPK3 PROTEIN, MOUSE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIVER CELL; LIVER TOXICITY; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL LINE; CHEMICAL AND DRUG INDUCED LIVER INJURY; DNA DAMAGE; DRUG EFFECTS; ENZYMOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; TIME FACTOR;

MUS;

ANIMALS; ANTHRACENES; CELL LINE; CHEMICAL AND DRUG INDUCED LIVER INJURY; DNA DAMAGE; ENZYME ACTIVATION; FUROSEMIDE; GLUTATHIONE DISULFIDE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TIME FACTORS;

EID: 84937555459     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2014.986250     Document Type: Article

References (27)

1. Bajt ML, Knight TR, Lemasters JJ, Jaeschke H. (2004). Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol Sci 80:343-9.
2. Cover C, Mansouri A, Knight TR, et al. (2005). Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. J Pharmacol Exp Ther 315:879-87.
3. Du K, Williams CD, McGill MR, et al. (2013). The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-Jun N-terminal kinase activation. Toxicol Appl Pharmacol 273:484-91.
4. Gautheron J, Vucur M, Reisinger F, et al. (2014). A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol Med 6:1062-74.
5. Grewal KK, Rafeiro E, Racz WJ. (1996). Bromobenzene and furosemide hepatotoxicity: alterations in glutathione, protein thiols, and calcium. Can J Physiol Pharmacol 74:257-64.
6. Gunawan BK, Liu ZX, Han D, et al. (2006). c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 131:165-78.
7. Hanawa N, Shinohara M, Saberi B, et al. (2008). Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 283:13565-77.
8. Jaeschke H, McGill MR, Ramachandran A. (2012). Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 44:88-106.
9. Jaeschke H, Mitchell JR. (1990). Use of isolated perfused organs in hypoxia and ischemia/reperfusion oxidant stress. Methods Enzymol 186:752-9.
10. Latchoumycandane C, Goh CW, Ong MM, Boelsterli UA. (2007). Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. Hepatology 45:412-21.
11. McGill MR, Li F, Sharpe MR, et al. (2014). Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans. Arch Toxicol 88:391-401.
12. McGill MR, Sharpe MR, Williams CD, et al. (2012). The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest 122:1574-83.
13. McGill MR, Yan HM, Ramachandran A, et al. (2011). HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology 53:974-82.
14. Mitchell JR, Nelson WL, Potter WZ, et al. (1976). Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther 199:41-52.
15. Mitchell JR, Potter WZ, Hinson JA, Jollow DJ. (1974). Hepatic necrosis caused by furosemide. Nature 251:508-11.
16. Qu Q, Liu J, Zhou HH, Klaassen CD. (2014). Nrf2 protects against furosemide-induced hepatotoxicity. Toxicology 324C:35-42.
17. Ramachandran A, McGill MR, Xie Y, et al. (2013). Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58:2099-108.
18. Randle LE, Goldring CE, Benson CA, et al. (2008). Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defense response pathway in CD-1 mice. Toxicology 43:249-60.
19. Saito C, Lemasters JJ, Jaeschke H. (2010). c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 46:8-17.
20. Theruvath TP, Snoddy MC, Zhong Z, Lemasters JJ. (2008). Mitochondrial permeability transition in liver ischemia and reperfusion: role of c-Jun N-terminal kinase 2. Transplantation 85:1500-4.
21. Vree TB, van der Ven AJ. (1999). Clinical consequences of the biphasic elimination kinetics for the diuretic effect of furosemide and its acyl glucuronide in humans. J Pharm Pharmacol 51:239-48.
22. Williams DP, Antoine DJ, Butler PJ, et al. (2007). The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore. J Pharmacol Exp Ther 322:1208-20.
23. Wang Y, Singh R, Lefkowitch JH, et al. (2006). Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J Biol Chem 281:15258-67.
24. Win S, Than TA, Han D, et al. (2011). c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem 286:35071-8.
25. Wong SG, Card JW, Racz WJ. (2000). The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity. Toxicol Lett 116:171-81.
26. Xie Y, McGill MR, Dorko K, et al. (2014). Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. Toxicol Appl Pharmacol 279:266-74.
27. Xie Y, Williams CD, McGill MR, et al. (2013). Purinergic receptor antagonist A438079 protects against acetaminophen-induced liver injury by inhibiting p450 isoenzymes, not by inflammasome activation. Toxicol Sci 131:325-35.